Nicox completes key data package for NCX 470 NDA submissions

Immusoft's ISP-002 granted US FDA Orphan Drug Designation in MPS II

Orphan Therapeutics Accelerator signs MoU with Fondazione Telethon

Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin

Amferia raises EUR3.5m to advance antimicrobial wound-care platform

Sobi s Aspaveli marketing authorisation receives positive European regulatory opinion

BoomRx launches centralised ordering platform directly to anti-aging community at A4M's Longevity Fest 2025

BioCryst wins FDA approval for oral HAE prophylaxis in young children

NanOlogy launches drug development program for diffuse intrinsic pontine glioma treatment

Neurizon Therapeutics' NUZ-001 regimen receives US FDA approval to proceed with the HEALEY ALS Platform Trial

Amgen's UPLIZNA receives US FDA approval

FDA grants priority review to Bristol Myers Squibb's Opdivo regimen for advanced Hodgkin lymphoma

Zydus Lifesciences enters licence and supply partnership with Formycon

Hikma launches TYZAVAN in US

Cereno Scientific's Phase IIb trial of CS1 in PAH approved by US FDA